Related Experiment Videos
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics
Marc Hafner1, Mario Niepel1, Peter K Sorger1
1HMS LINCS Center, Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
Nature Biotechnology
|June 8, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trial.
Nature communications·2026
Compositional and interpretable representation of histology using AI foundation models and sparse autoencoders.
bioRxiv : the preprint server for biology·2026
Modeling development of tertiary lymphoid structures in pulmonary tuberculosis by 3D profiling and trajectory analysis.
bioRxiv : the preprint server for biology·2026
Volumetric Cyclic Immunofluorescence for 3D Spatial Profiling of Immune Structures in Human FFPE Tissue.
bioRxiv : the preprint server for biology·2026
AI-enhanced adaptive virtual screening of large libraries for ligand discovery.
Nature biotechnology·2026
A pervasive RT-qPCR artifact inflates RNA knockdown by RNA-targeting CRISPR.
Nature biotechnology·2026
Macropinocytosis-mediated recyclable LYTACs (McR-TACs) for receptor-independent protein degradation.
Nature biotechnology·2026
A genomic catalog of Earth's bacterial and archaeal symbionts.
Nature biotechnology·2026
Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology.
Acta oncologica (Stockholm, Sweden)·2026
Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.
Journal of the National Cancer Institute·2026
Predicting pancreatic cancer in high-risk individuals and in the general population: how long is the road yet?
Revista espanola de enfermedades digestivas·2026